| Michael Stephen Roman, | |
|
2032 E Pleasant Valley Blvd, Altoona, PA 16602-7515 | |
| (814) 944-9998 | |
| Not Available |
| Full Name | Michael Stephen Roman |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2032 E Pleasant Valley Blvd, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013518075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP044072L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Stephen Roman, 2032 E Pleasant Valley Blvd, Altoona, PA 16602-7515 Ph: (814) 944-9998 | Michael Stephen Roman, 2032 E Pleasant Valley Blvd, Altoona, PA 16602-7515 Ph: (814) 944-9998 |
News Archive
What many Americans eat and how little they exercise could wind up costing them - and American taxpayers - some serious money. Moreover, the overweight and obese may lose months from their lifespans.
Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug called AT-406 with potential to treat multiple types of cancer.
Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
Sucampo Pharmaceuticals, Inc. and Abbott today announced positive top-line data from a 48-week phase 3 long-term safety and efficacy clinical trial of lubiprostone in Japanese patients with chronic idiopathic constipation (CIC). The trial demonstrated that lubiprostone was safe and well-tolerated.
› Verified 8 days ago
Dr. Adam Edward Lang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2907 Pleasant Valley Blvd, Altoona, PA 16602 Phone: 877-626-2500 | |
Stephanie Wyman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 E Plank Rd, Altoona, PA 16602 Phone: 814-944-9224 | |
Rahaf Obeid, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 508 E Plank Road, Altoona, PA 16602 Phone: 814-944-3236 | |
Elizabeth Ann Abraham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Logan Blvd, Altoona, PA 16602 Phone: 814-949-3735 Fax: 814-949-3729 | |
Kimberly Ann Dudzinski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 181 Sophrira Ln, Altoona, PA 16602 Phone: 814-946-4267 | |
Terry Mcginnis, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 508 E Plank Rd, Altoona, PA 16602 Phone: 814-944-3236 |